Literature DB >> 9861209

Prostate cancer: 7. Radiation therapy for localized disease.

P Warde1, C Catton, M K Gospodarowicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9861209      PMCID： PMC1229858     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  30 in total

1.  Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity.

Authors:  T Teshima; G E Hanks; A L Hanlon; R S Peter; T E Schultheiss
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-08-01       Impact factor: 7.038

2.  Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.

Authors:  M Bolla; D Gonzalez; P Warde; J B Dubois; R O Mirimanoff; G Storme; J Bernier; A Kuten; C Sternberg; T Gil; L Collette; M Pierart
Journal:  N Engl J Med       Date:  1997-07-31       Impact factor: 91.245

3.  Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer.

Authors:  J Laverdière; J L Gomez; L Cusan; E R Suburu; P Diamond; M Lemay; B Candas; A Fortin; F Labrie
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-01-15       Impact factor: 7.038

4.  Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up.

Authors:  H Ragde; J C Blasko; P D Grimm; G M Kenny; J Sylvester; D C Hoak; W Cavanagh; K Landin
Journal:  Semin Surg Oncol       Date:  1997 Nov-Dec

5.  Radiation therapy as treatment for stage T1c prostate cancers.

Authors:  G E Hanks; A L Hanlon; W H Pinover; T I al-Saleem; T E Schultheiss
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

6.  External beam radiotherapy dose response of prostate cancer.

Authors:  A Pollack; G K Zagars
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-12-01       Impact factor: 7.038

Review 7.  Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results.

Authors:  A L Zietman; E A Prince; B M Nakfoor; W U Shipley
Journal:  Urology       Date:  1997-03       Impact factor: 2.649

8.  A feasibility study of automated inverse treatment planning for cancer of the prostate.

Authors:  L E Reinstein; X H Wang; C M Burman; Z Chen; R Mohan; G Kutcher; S A Leibel; Z Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

9.  Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; D Schultz; K Blank; G A Broderick; J E Tomaszewski; A A Renshaw; I Kaplan; C J Beard; A Wein
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

10.  Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

Authors:  M J Zelefsky; S A Leibel; P B Gaudin; G J Kutcher; N E Fleshner; E S Venkatramen; V E Reuter; W R Fair; C C Ling; Z Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-06-01       Impact factor: 7.038
View more
  9 in total

1.  Prostate cancer from a patient's perspective.

Authors:  D Grundy
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

2.  Understanding obesity.

Authors:  J D Douketis
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

3.  The more the better?

Authors:  M Simunovic; T To; B Langer
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

4.  Understanding obesity.

Authors:  T M Stein
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

5.  PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.

Authors:  M Greiver; N Rosen
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

Review 6.  Prostate cancer: 11. Alternative approaches and the future of treatment.

Authors:  J Trachtenberg; J Crook; I F Tannock
Journal:  CMAJ       Date:  1999-02-23       Impact factor: 8.262

7.  Unforeseen complication of brachytherapy.

Authors:  Ian Dayes; Jink Sathya; Ian Davis
Journal:  CMAJ       Date:  2004-04-13       Impact factor: 8.262

8.  Should Canadians be offered systematic prostate cancer screening? No.

Authors:  Michel Labrecque; France Légaré; Michel Cauchon
Journal:  Can Fam Physician       Date:  2007-06       Impact factor: 3.275

9.  Prostate cancer: 8. Urinary incontinence and erectile dysfunction.

Authors:  M M Hassouna; J P Heaton
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.